You are here:

collagenase clostridum histolyticum (Xiapex)

Advice

in the absence of a submission from the holder of the marketing authorisation

collagenase clostridium histolyticum (Xiapex)®) is not recommended for use within NHS Scotland.

Indication under review: treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: collagenase clostridum histolyticum (Xiapex)
SMC Drug ID: 1059/15
Manufacturer: Swedish Orphan
Indication: Treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.
BNF Category:
Sub Category: 10.3 Drugs for the relief of soft tissue inflamation
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 11 May 2015

Back